Doctor profile · Federal record
Dr. SATISH CHADA, M.D.
Critical Care Medicine (Internal Medicine) Physician (CMS: CRITICAL CARE (INTENSIVISTS)) · Pulmonary Disease Physician · WICHITA FALLS, TX
- NPI 1215915558
- Accepts Medicare
- MIPS 93.5 / 100 · 2023
- 32 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1208 BROOK AVE
WICHITA FALLS, TX 763015602
(940) 322-4480
fax (940) 322-8420
Credentials & registration
- NPI registered
- January 2006 — 20 yrs on file
- Profile last updated
- August 29, 2024
- Year of graduation
- 1994 — 32 yrs since
- Specialty taxonomy
- 207RC0200X — NUCC code
- State license (1)
- Texas #M0683
- Medicaid
- TX #1753410-01
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1215915558. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,379
Distinct HCPCS
10
Medicare allowed
$257,250
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 568 | 358 | $124 | |
99291 |
Critical care, first 30-74 minutes | 486 | 213 | $204 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 150 | 102 | $76 | |
94729 |
Test to examine how well the lungs exchange gases | 147 | 146 | $54 | |
94726 |
Test to determine lung volumes using sensors | 143 | 142 | $52 | |
94618 |
Test for exercise-induced lung stress | 139 | 138 | $33 | |
94060 |
Test to measure expiratory airflow and volume changes before and after medication administration | 87 | 87 | $37 | |
96372 |
Injection of drug or substance under skin or into muscle | 85 | 11 | $13 | |
95811 |
Sleep study in sleep lab with continuous airway pressure (6 years or older) | 80 | 79 | $119 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 77 | 77 | $162 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 106. This provider delivers 22× the peer median.Open Payments
Industry payments received
All-time total
$2,887
Transactions
146
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GlaxoSmithKline, LLC. | 32 | $509.37 | |
| AstraZeneca Pharmaceuticals LP | 22 | $454.96 | |
| GENZYME CORPORATION | 17 | $423.39 | |
| Regeneron Healthcare Solutions, Inc. | 17 | $294.27 | |
| Mylan Specialty L.P. | 16 | $272.18 | |
| Amgen Inc. | 10 | $191.08 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $125.35 | |
| United Therapeutics Corporation | 4 | $110.63 | |
| Actelion Pharmaceuticals US, Inc. | 5 | $103.55 | |
| Merck Sharp & Dohme LLC | 5 | $101.16 | |
| PFIZER INC. | 5 | $91.67 | |
| Novartis Pharmaceuticals Corporation | 2 | $42.01 | |
| Baxter Healthcare | 2 | $41.40 | |
| Philips North America LLC | 2 | $40.48 | |
| Grifols USA, LLC | 2 | $30.91 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,403
Patients
317
Total drug cost
$1,252,898
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 489 | 104 | $407,696 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 219 | 67 | $6,790 |
| Montelukast Sodium | Generic | 161 | 41 | $2,735 |
| Breztri Aerosphere (Budesonide/Glycopyr/Formoterol) | Brand | 116 | 25 | $77,102 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 69 | 15 | $48,236 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 60 | 15 | $51,755 |
| Ofev (Nintedanib Esylate) | Brand | 47 | 0 | $590,144 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 45 | 13 | $23,969 |
| Ventolin Hfa (Albuterol Sulfate) | Brand | 38 | 23 | $2,306 |
| Ipratropium Bromide | Generic | 33 | 0 | $1,431 |